• Thu, February 22, 2024

Robert Wasserman Upgraded (ABCL) to Strong Buy on, Feb 22nd, 2024

Robert Wasserman of Benchmark, Upgraded "AbCellera Biologics Inc." (ABCL) to Strong Buy on, Feb 22nd, 2024.

Robert has made no other calls on ABCL in the last 4 months.



There are 2 other peers that have a rating on ABCL. Out of the 2 peers that are also analyzing ABCL, 0 agree with Robert's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Robert


  • Stephen Willey of "Stifel" Maintained at Strong Buy with Decreased Target to $17 on, Wednesday, February 21st, 2024
  • Scott Schoenhaus of "Keybanc" Initiated at Buy and Held Target at $6 on, Tuesday, December 5th, 2023

Like: 👍